The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Pharmaceutical Lipid-Based Excipients Market In 2026 And 2030?
The market size for pharmaceutical lipid-based excipients has experienced significant growth in recent years. It is projected to expand from $1.77 billion in 2025 to $1.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.2%. Historically, this growth can be attributed to several factors, including an increase in poorly water-soluble drug pipelines, advancements in lipid formulation science, the expansion of pharmaceutical manufacturing, the rising use of oral delivery systems, and regulatory support for lipid excipients.
The pharmaceutical lipid-based excipients market is anticipated to show substantial growth over the next few years, projected to swell to $2.29 billion in 2030, registering a compound annual growth rate (CAGR) of 5.3%. This expansion during the forecast period is attributed to several factors including the increase in complex drug formulations, a rising need for enhanced drug absorption, the broadening scope of biologics and oncology drugs, ongoing advancements in lipid technologies, and a heightened emphasis on patient-centric formulations. Major trends expected in this period encompass the expanded use of lipid excipients for poorly soluble drugs, their growing adoption in both oral and parenteral formulations, an increasing demand for excipients that enhance bioavailability, the expansion of lipid-based drug delivery systems, and a strengthened focus on natural and sustainable lipids.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
Which Growth Drivers Are Expected To Support The Pharmaceutical Lipid-Based Excipients Market Forward?
The projected increase in gene therapy is poised to stimulate the growth of the pharmaceutical lipid-based excipients market. Gene therapy is a medical approach that involves modifying or manipulating a person’s genes to address or prevent diseases. The escalation in gene therapy is attributed to advancements in delivery systems, as these systems enable the safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients enhance gene therapy by facilitating effective delivery systems, ensuring the stability and targeted transport of genetic material. They contribute to better therapeutic outcomes by protecting nucleic acids and promoting cellular uptake, thereby improving the effectiveness of modern treatments. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, which was an increase from five approvals in 2022. Thus, the expansion of gene therapy is driving the growth of the pharmaceutical lipid-based excipients market.
What Key Segment Areas Are Included In The Pharmaceutical Lipid-Based Excipients Market Assessment?
The pharmaceutical lipid-based excipients market covered in this report is segmented –
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users
Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids
Which Trends Are Expected To Shape The Pharmaceutical Lipid-Based Excipients Market?
Companies operating within the pharmaceutical lipid-based excipients market are prioritizing investments, including strategic funding, to establish advanced Centers of Excellence. These centers are designed to foster innovation, improve formulation skills, support research in drug delivery, and strengthen their market standing in emerging therapeutic areas. An illustration of this trend is Gattefossé SAS, a French chemical manufacturing company, which in November 2024, launched a state-of-the-art Technical Center of Excellence in Mumbai. This facility aims to assist India’s burgeoning pharmaceutical sector by providing specialized laboratories and customized support for excipient innovation, with a particular focus on enhancing bioavailability, sustained release, and topical formulations, while simultaneously solidifying the company’s presence across the Asia-Pacific region. This modern facility integrates pharmaceutical and personal care application laboratories to cultivate innovation, encourage cooperative efforts, and provide an effective working environment.
Which Organizations Are Involved In The Pharmaceutical Lipid-Based Excipients Market?
Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth
Access The Complete Pharmaceutical Lipid-Based Excipients Market Report:
Which Regional Market Leads The Pharmaceutical Lipid-Based Excipients Market?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Pharmaceutical Lipid-Based Excipients Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Lipid-Based Excipients Market 2026, By The Business Research Company
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Organic Pharmaceutical Excipients Market Report 2026
Liposomal Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model